EAN 2017

The neuropathology and genetics of ALS and FTD

ASL MRI as an early biomarker for Alzheimer’s disease

ALS and frontotemporal dementia: on a continuum or part of a spectrum of disorders?

Challenges of managing the neuropsychiatric symptoms of Alzheimer’s and vascular dementia

A novel biomarker of Alzheimer’s disease progression: LTP-like cortical plasticity

Angiotensin receptor blockers on cognitive function in Alzheimer’s disease

APOE haplotypes, ACE insertion/deletion polymorphism and neuropsychiatric symptoms in Alzheimer’s

Investigating physical activity and Alzheimer’s disease

Challenges with comorbidities and dementia

Pioglitazone for the treatment of Alzheimer’s disease

Outcome measures and comorbidities in dementia

Strategies for the prevention of vascular cognitive impairment

Cerebrospinal fluid (CSF) and imaging biomarkers for the differential diagnosis of dementia

Dementia, it’s not only Alzheimer’s disease

Risk factors for developing dementia

Cognitive performance stays stable in chronic kidney disease patients over a 2-year period